{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:25:48Z","timestamp":1793877948290,"version":"4.7.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.esmoop.2022.100740","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:10:05Z","timestamp":1671754205000},"page":"100740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of EGFRA289T\/V mutation on relapse pattern in glioblastoma"],"prefix":"10.1016","volume":"8","author":[{"given":"A.","family":"Noeuveglise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sarafan-Vasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Beaussire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Marguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Modzelewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hanzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Alexandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Clatot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fontanilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2022.100740_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100740_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2010.08.020","article-title":"Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide","volume":"97","author":"Minniti","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1748-717X-9-130","article-title":"Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide","volume":"9","author":"Gebhardt","year":"2014","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2009.10.048","article-title":"Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma","volume":"79","author":"McDonald","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12885-021-08467-3","article-title":"Limited recurrence distance of glioblastoma under modern radiotherapy era","volume":"21","author":"Tu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.esmoop.2022.100740_bib6","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100740_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","article-title":"Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status","volume":"27","author":"Brandes","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100740_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1215\/15228517-2008-058","article-title":"A\u00a0novel tool to analyze MRI recurrence patterns in glioblastoma","volume":"10","author":"Wick","year":"2008","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100740_bib9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ccell.2018.06.006","article-title":"Epidermal growth factor receptor extracellular domain mutations in glioblastoma present opportunities for clinical imaging and therapeutic development","volume":"34","author":"Binder","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100740_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100740_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100740_bib13","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","article-title":"Short-course radiation plus temozolomide in elderly patients with glioblastoma","volume":"376","author":"Perry","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib14","doi-asserted-by":"crossref","first-page":"CNS28","DOI":"10.2217\/cns-2018-0007","article-title":"Use of the response assessment in neuro-oncology (RANO) criteria in clinical trials and clinical practice","volume":"8","author":"Chukwueke","year":"2019","journal-title":"CNS Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100740_bib15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s00259-015-3004-y","article-title":"High FDG uptake areas on pre-radiotherapy PET\/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer","volume":"42","author":"Calais","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.esmoop.2022.100740_bib16","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.canrad.2016.07.008","article-title":"R\u00e9f\u00e9rentiels d\u2019irradiation des gliomes","volume":"20","author":"Feuvret","year":"2016","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"22","key":"10.1016\/j.esmoop.2022.100740_bib17","first-page":"00640","article-title":"Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma","volume":"S0035-3787","author":"Fontanilles","year":"2022","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100740_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.209601.116","article-title":"UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy","volume":"27","author":"Smith","year":"2017","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100740_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-020-00917-6","article-title":"Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma","volume":"8","author":"Fontanilles","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100740_bib20","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/bioinformatics\/btw325","article-title":"GenVisR: genomic visualizations in R","volume":"32","author":"Skidmore","year":"2016","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100740_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215838","article-title":"Mutplot: an easy-to-use online tool for plotting complex mutation data with flexibility","volume":"14","author":"Zhang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.esmoop.2022.100740_bib22","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1016\/j.wneu.2017.10.052","article-title":"Epidermal growth factor receptor expression predicts time and patterns of recurrence in patients with glioblastoma after radiotherapy and temozolomide","volume":"109","author":"Tini","year":"2018","journal-title":"World Neurosurg"},{"issue":"7897","key":"10.1016\/j.esmoop.2022.100740_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41586-021-04393-3","article-title":"Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias","volume":"602","author":"Hu","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100740_bib24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ijrobp.2021.03.032","article-title":"Initial results of a phase 2 trial of 18F-DOPA PET-guided dose-escalated radiation therapy for glioblastoma","volume":"110","author":"Laack","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100740_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2021.01.033","article-title":"A\u00a0phase 2 study of dose-intensified chemoradiation using biologically based target volume definition in patients with newly diagnosed glioblastoma","volume":"110","author":"Kim","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.esmoop.2022.100740_bib26","first-page":"noac204","article-title":"EGFR, the Lazarus target for precision oncology in glioblastoma","author":"Lin","year":"2022","journal-title":"Neuro Oncol"},{"issue":"7804","key":"10.1016\/j.esmoop.2022.100740_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and therapeutic implications of hypermutation in gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100740_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1101\/gr.180612.114","article-title":"Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution","volume":"25","author":"Kim","year":"2015","journal-title":"Genome Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292200374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292200374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:30:46Z","timestamp":1761856246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292200374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S205970292200374X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100740","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of EGFRA289T\/V mutation on relapse pattern in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100740"}}